UBS Group
THQ

UBS Group’s abrdn Healthcare Opportunities Fund THQ Stock Holding History

UBS Group’s Portfolio THQ Stock Details THQ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.68M Sell
196,425
-111,799
-36% -$2.04M ﹤0.01% 4482
2026
Q1 		$5.18M Buy
308,224
+12,611
+4% +$237K ﹤0.01% 4053
2025
Q4 		$5.66M Buy
295,613
+11,553
+4% +$212K ﹤0.01% 3900
2025
Q3 		$4.91M Sell
284,060
-7,492
-3% -$128K ﹤0.01% 4055
2025
Q2 		$5.36M Sell
291,552
-59,199
-17% -$1.1M ﹤0.01% 3802
2025
Q1 		$7.24M Buy
350,751
+27,862
+9% +$569K ﹤0.01% 3398
2024
Q4 		$6.09M Buy
322,889
+25,582
+9% +$529K ﹤0.01% 3606
2024
Q3 		$6.56M Buy
297,307
+8,880
+3% +$190K ﹤0.01% 2790
2024
Q2 		$5.88M Sell
288,427
-7,504
-3% -$149K ﹤0.01% 2697
2024
Q1 		$5.95M Sell
295,931
-2,862
-1% -$55K ﹤0.01% 2790
2023
Q4 		$5.41M Sell
298,793
-13,906
-4% -$235K ﹤0.01% 2704
2023
Q3 		$5.31M Sell
312,699
-9,391
-3% -$174K ﹤0.01% 2509
2023
Q2 		$6.14M Buy
322,090
+11,661
+4% +$220K ﹤0.01% 2379
2023
Q1 		$5.82M Buy
310,429
+5,183
+2% +$99.2K ﹤0.01% 2371
2022
Q4 		$6.05M Sell
305,246
-91,030
-23% -$1.8M ﹤0.01% 2318
2022
Q3 		$7.18M Buy
396,276
+109,496
+38% +$2.19M ﹤0.01% 2051
2022
Q2 		$5.72M Buy
286,780
+7,923
+3% +$166K ﹤0.01% 2264
2022
Q1 		$6.21M Buy
278,857
+13,028
+5% +$291K ﹤0.01% 2335
2021
Q4 		$6.82M Buy
265,829
+268
+0.1% +$6.44K ﹤0.01% 2509
2021
Q3 		$6.01M Sell
265,561
-10,158
-4% -$245K ﹤0.01% 2478
2021
Q2 		$6.37M Sell
275,719
-1,537
-0.6% -$35.3K ﹤0.01% 2440
2021
Q1 		$6.03M Sell
277,256
-4,782
-2% -$100K ﹤0.01% 2414
2020
Q4 		$5.75M Sell
282,038
-18,814
-6% -$359K ﹤0.01% 2314
2020
Q3 		$5.44M Buy
300,852
+9,973
+3% +$181K ﹤0.01% 2120
2020
Q2 		$5.18M Buy
290,879
+17,067
+6% +$301K ﹤0.01% 2025
2020
Q1 		$4.21M Buy
273,812
+6,080
+2% +$107K ﹤0.01% 2082
2019
Q4 		$5.11M Buy
267,732
+8,594
+3% +$156K ﹤0.01% 2584
2019
Q3 		$4.53M Buy
259,138
+3,455
+1% +$60.6K ﹤0.01% 2476
2019
Q2 		$4.56M Buy
255,683
+25,696
+11% +$441K ﹤0.01% 2403
2019
Q1 		$4.05M Sell
229,987
-51,703
-18% -$902K ﹤0.01% 2379
2018
Q4 		$4.73M Buy
281,690
+15,913
+6% +$282K ﹤0.01% 2202
2018
Q3 		$4.98M Sell
265,777
-15,199
-5% -$275K ﹤0.01% 2344
2018
Q2 		$4.79M Sell
280,976
-40,795
-13% -$684K ﹤0.01% 2378
2018
Q1 		$5.3M Buy
321,771
+62,462
+24% +$1.09M ﹤0.01% 2245
2017
Q4 		$4.54M Sell
259,309
-1,567
-0.6% -$27.9K ﹤0.01% 2446
2017
Q3 		$4.84M Sell
260,876
-13,405
-5% -$246K ﹤0.01% 2240
2017
Q2 		$5.03M Buy
274,281
+7,146
+3% +$126K ﹤0.01% 2144
2017
Q1 		$4.65M Sell
267,135
-53,195
-17% -$907K ﹤0.01% 2136
2016
Q4 		$4.97M Sell
320,330
-21,225
-6% -$344K ﹤0.01% 2101
2016
Q3 		$5.97M Buy
341,555
+9,161
+3% +$159K ﹤0.01% 1862
2016
Q2 		$5.53M Sell
332,394
-22,437
-6% -$366K ﹤0.01% 1862
2016
Q1 		$5.64M Sell
354,831
-22,560
-6% -$349K ﹤0.01% 1759
2015
Q4 		$6.56M Sell
377,391
-35,119
-9% -$603K ﹤0.01% 1741
2015
Q3 		$6.72M Buy
412,510
+33,866
+9% +$648K ﹤0.01% 1682
2015
Q2 		$7.51M Buy
378,644
+39,416
+12% +$809K 0.01% 1709
2015
Q1 		$6.98M Buy
339,228
+103,299
+44% +$2.08M ﹤0.01% 1768
2014
Q4 		$4.73M Buy
+235,929
New +$4.58M ﹤0.01% 2133

Other funds holding THQ

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
HBCM
Heron Bay Capital Management Bloomfield Hills, Michigan $1.1B AUM 11.31% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

UBS Group's THQ Position: Q2 2026 in Review

UBS Group reduced its abrdn Healthcare Opportunities Fund (THQ) stake by 36% in Q2 2026, selling an estimated $2.04M and leaving 196,425 shares worth $3.68M. The position accounts for ﹤0.01% of the portfolio, ranked #4482.

UBS Group first reported a position in THQ in Q4 2014 and has held it in 47 quarters since. The position peaked at $7.51M in Q2 2015. 97 funds tracked by Wall St. Rank hold THQ as of Q2 2026.

  • UBS Group held 196,425 shares of abrdn Healthcare Opportunities Fund worth $3.68M as of Q2 2026.
  • UBS Group sold 111,799 abrdn Healthcare Opportunities Fund shares in Q2 2026, an estimated $2.04M.
  • abrdn Healthcare Opportunities Fund made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #4482 holding.
  • UBS Group first reported a position in abrdn Healthcare Opportunities Fund in Q4 2014 and has held it in 47 quarters since.
  • UBS Group's abrdn Healthcare Opportunities Fund position peaked at $7.51M in Q2 2015.
  • 97 funds tracked by Wall St. Rank held abrdn Healthcare Opportunities Fund as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.